Safety and Immunogenicity of a Novel Vaccine Formulation MV-ZIKA-RSP

Condition:   Zika Virus Infection Interventions:   Biological: Two MV-ZIKA-RSP vaccinations (high dose);   Biological: Two MV-ZIKA-RSP vaccination (low dose);   Biological: One MV-ZIKA-RSP vaccination (high dose) and one placebo;   Other: Two placebo injection Sponsor:   Themis Bioscience GmbH Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials